Table 1 Demographic and past medical history and drugs in RTRs and nonRTRs
| Â | Â | Group | P | ||
|---|---|---|---|---|---|
Transplant Pts | Non-transplant Pts | Total | |||
Count (N %) | Count (N %) | Count (N %) | |||
Age group | Low—50 yrs | 11 (45.8) | 16 (40.0) | 27 (42.2) | 0.491 |
|  | 50—59 yrs | 4 (16.7) | 12 (30.0) | 16 (25.0) |  |
|  | 60—high yrs | 9 (37.5) | 12 (30.0) | 21 (32.8) |  |
Age | 52.25 ± 12.88 (29.00 – 76.00) | 51.58 ± 11.32 (32.0 – 72.0) | 51.83 ± 11.83 (29.0 – 76.0) |  |  |
Sex | Male | 17 (70.8) | 24 (60.0) | 41 (64.1) | 0.431 |
| Â | Female | 7 (29.2) | 16 (40.0) | 23 (35.9) | Â |
HTN |  | 20 (87.0) | 16 (41.0) | 36 (58.1) |  < 0.001 |
Diabetes | Â | 11 (47.8) | 12 (30.8) | 23 (37.1) | 0.179 |
CVA | Â | 1 (4.3) | 1 (2.6) | 2 (3.2) | 0.608 |
IHD or HF | Â | 4 (17.4) | 8 (20.5) | 12 (19.4) | 0.520 |
DVT | Â | 1 (4.3) | 0 (0.0) | 1 (1.6) | 0.371 |
PTE | Â | 0 (0.0) | 1 (2.6) | 1 (1.6) | 0.621 |
COPD | Â | 1 (4.3) | 7 (17.9) | 8 (12.9) | 0.123 |
Cellcept | Â | 24 (12.9) | Â | 24 (100.0) | - |
Cyclosporine | Â | 13 (56.5) | Â | 13 (56.5) | Â |
Tacrolimus | Â | 9 (40.9) | Â | 9 (40.9) | Â |
Sirolimus | Â | 1 (4.3) | Â | 1 (4.3) | Â |
Corticosteroid | Â | 23 (95.8) | 4 (10.0) | 27 (42.2) | 0.001 |
ARB or ACEi | Â | 6 (25.0) | 13 (34.2) | 22 (36.7) | 0.444 |
Atorvastatin | Â | 20 (83.3) | 13 (34.2) | 31 (50.8) | 0.001 |
Warfarin | Â | 1 (4.3) | 2 (5.3) | 3 (4.9) | 0.684 |
HCQ | Â | 23 (95.8) | 40 (100.0) | 63 (98.4) | 0.375 |
Kaletra | Â | 17 (70.8) | 30 (75.0) | 47 (73.4) | 0.715 |
Tamiflu | Â | 16 (66.7) | 21 (52.5) | 37 (57.8) | 0.267 |
Azithromycin | Â | 2 (8.3) | 8 (20.0) | 10 (15.6) | 0.189 |
IVIG | Â | 4 (16.7) | 0 (0.0) | 4 (6.3) | 0.017 |
Gancyclovir | Â | 1 (4.2) | 0 (0.0) | 1 (1.6) | 0.375 |
Ribavirin | Â | 2 (8.3) | 0 (0.0) | 2 (3.1) | 0.137 |